CRVL

Business Context and Reporting Period

Company: CorVel Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2009
Business Overview: CorVel is an independent nationwide provider of medical cost containment and managed care services, primarily for workers' compensation and auto policies. The company operates in one reportable segment: managed care, delivering patient management and network solutions services to insurance companies, third-party administrators, and self-administered employers.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Revenues increased by $3.1 million (4.0%) year-over-year. This was driven primarily by a $2.3 million increase in network solutions revenue due to higher bill volume on large out-of-network bills. Patient management revenue increased nominally by $0.9 million.
• Profitability: Net income rose by $0.8 million (15.0%) to $6.4 million. Diluted earnings per share increased by 22.5% to $0.49, aided by higher operating income and a reduction in weighted average shares outstanding due to stock repurchases.
• Expense Management: General and administrative expenses decreased by $0.3 million (3.3%), primarily due to reduced systems and data interface costs ($0.8 million decrease) offset by higher marketing and administrative staffing costs.
• Cash Flow: Net cash provided by operating activities decreased by $0.6 million (7.1%) to $7.8 million, largely due to an increase in accounts receivable and a decrease in accounts payable compared to the prior year.
• Liquidity: Cash and cash equivalents increased by $5.6 million during the quarter to $20.2 million. The company maintains a $10 million revolving credit facility with no outstanding borrowings as of June 30, 2009.

Outlook, Risks, and Unusual Items

• Guidance and Outlook: Management notes that revenue and margin growth are difficult to attain due to a flat-to-declining workers' compensation market, price competition, and a decrease in manufacturing jobs leading to fewer workplace injuries. The company expects referral volume and bill review volume to reflect nominal growth or decrease until work-related injuries increase.
• Internal Controls: The company disclosed a material weakness in internal control over financial reporting as of March 31, 2009, related to financial close and reporting processes (e.g., reconciliations, use of Excel for consolidation). Remediation activities were underway as of June 30, 2009, but management could not yet conclude on their effectiveness.
• Legal Proceedings: A putative class action lawsuit filed in 2005 by Kathleen Roche, D.C., regarding alleged failure to direct patients to PPO network providers and use of biased software, remains pending. The company cannot estimate the potential loss.
• Stock Repurchases: The company repurchased 29,676 shares for $0.6 million during the quarter. As of June 30, 2009, 437,581 shares remained available for purchase under the authorized program.

Investor Verification Checklist

• Internal Control Remediation: Verify the status and effectiveness of the remediation plan for the material weakness in financial reporting controls.
• Legal Exposure: Monitor the status of the Roche class action lawsuit and any potential financial impact.
• Market Trends: Assess the impact of declining manufacturing employment and workers' compensation claim volumes on future revenue growth.
• Customer Concentration: Confirm that no single customer accounts for more than 10% of revenue or accounts receivable (as stated in the filing).
• Debt Covenants: Review compliance with the new $10 million credit facility covenants (current ratio of 1.25:1, debt-to-tangible net worth not greater than 1:1).